South Korean researchers claim magnetic gene switch breakthrough amid skepticism

Researchers at Dongguk University in Seoul have developed a magnetically controlled switch for turning on genes inside cells, as detailed in a recent Cell paper. The technique uses a specific electromagnetic signal to activate genes in mice and human cells. Critics, however, question the plausibility of the results and point to potential flaws in the study.

Jongpil Kim and his team at Dongguk University report creating a switch that activates the promoter sequence for the LGR4 gene using a 4-kilohertz electromagnetic square wave at 2 millitesla strength, modulated at 60 hertz. This induces calcium ion oscillations in cells engineered with cytochrome b5 protein, triggering gene expression. The method worked in various human cells and mice, with no detectable effects on unmodified animals, according to the paper published in Cell (DOI: 10.1016/j.cell.2026.03.029). Kim states the precise biophysical mechanism remains under investigation but emphasizes the signal's safety for potential medical use, such as controlling therapeutic protein production deep in the body. His team is collaborating with biotech companies and institutions, with plans to disclose datasets in future publications. The approach addresses optogenetics' limitations, where light cannot penetrate far into tissues, potentially enabling non-invasive control of biological processes for treatments and research. Physicist Andrew York calls the claim 'wild' and 'game-changing,' urging replication before publication, noting the paper's three-year review allowed time for independent verification. He deems the near-minute oscillation from a 60-Hz signal implausible and the calcium response's magnitude suspiciously selective, affecting only one gene without broader impacts. Kim counters that internal cell processes govern the oscillation period, not the signal frequency, and the response stays within physiological norms. Additional concerns include a luminescence figure showing activity before activation—dismissed by Kim as a curve-smoothing artifact—and a duplicated, flipped image in figure S5P, attributed to a clerical error now under correction with Cell. The publisher has not yet responded to inquiries.

Связанные статьи

Scientists in a lab boosting MeCP2 protein levels to treat Rett syndrome, showing restored neurons and mouse models.
Изображение, созданное ИИ

Scientists raise MeCP2 levels by shifting MECP2 splicing in early Rett syndrome studies

Сообщено ИИ Изображение, созданное ИИ Проверено фактами

Researchers at Texas Children’s Hospital’s Duncan Neurological Research Institute and Baylor College of Medicine report an experimental gene-targeting approach designed to increase levels of the MeCP2 protein disrupted in Rett syndrome. In mouse experiments and neurons derived from patient cells, the strategy boosted MeCP2 and partially restored cellular structure, electrical activity and gene-expression patterns, according to findings published in Science Translational Medicine.

Scientists at the University of Basel and ETH Zurich have reversed the polarity of a specialized ferromagnet with a focused laser beam, without heating the material. This achievement, detailed in Nature, combines electron interactions, topology, and dynamical control in a single experiment. The method hints at future light-based electronic circuits on chips.

Сообщено ИИ

Scientists at EPFL have developed a technique called optovolution, using light to evolve proteins that switch states, sense environments, and perform computations. By engineering yeast cells to survive only if proteins behave dynamically, the method selects optimal variants rapidly. The approach, published in Cell, advances synthetic biology and optogenetics.

Researchers at Harvard’s Wyss Institute and Dana-Farber Cancer Institute report that a DNA origami-based vaccine platform called DoriVac generated robust immune responses in mice and in a human lymph node “Organ Chip” model. The team says the approach could be easier to store and manufacture than lipid nanoparticle–delivered mRNA vaccines, though the work remains preclinical. The results were published in Nature Biomedical Engineering.

Сообщено ИИ Проверено фактами

Researchers at Kyoto University and RIKEN report that human cells can detect “non-optimal” synonymous codons—alternative three-letter genetic instructions that encode the same amino acid but are translated less efficiently—and selectively suppress the corresponding mRNAs. In experiments described in Science, the team identifies the RNA-binding protein DHX29 as a central component of this codon-dependent control of gene expression.

Этот сайт использует куки

Мы используем куки для анализа, чтобы улучшить наш сайт. Прочитайте нашу политику конфиденциальности для дополнительной информации.
Отклонить